Drug
DNL343
DNL343 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
3
60%
Ph phase_2
2
40%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed480%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingphase_2
HEALEY ALS Platform Trial - Master Protocol
NCT04297683
completedphase_2
HEALEY ALS Platform Trial - Regimen G DNL343
NCT05842941
completedphase_1
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT05006352
completedphase_1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers
NCT04268784
completedphase_1
A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers
NCT04581772
Clinical Trials (5)
Showing 5 of 5 trials
NCT04297683Phase 2
HEALEY ALS Platform Trial - Master Protocol
NCT05842941Phase 2
HEALEY ALS Platform Trial - Regimen G DNL343
NCT05006352Phase 1
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT04268784Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers
NCT04581772Phase 1
A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5